This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1975 Sep;2(3):215-24.

doi: 10.1016/s0305-7372(75)80004-1.

Anti-folate resistance in leukemia: treatment with "high-dose" methotrexate and citrovorum factor

PMID: 1104164
DOI: 10.1016/s0305-7372(75)80004-1

Review

Anti-folate resistance in leukemia: treatment with "high-dose" methotrexate and citrovorum factor

R A Bender. Cancer Treat Rev. 1975 Sep.

. 1975 Sep;2(3):215-24.

doi: 10.1016/s0305-7372(75)80004-1.

Author

PMID: 1104164
DOI: 10.1016/s0305-7372(75)80004-1

No abstract available

PubMed Disclaimer

Similar articles

New approaches to chemotherapy with folate antagonists: use of leucovorin "rescue" and enzymic folate depletion.
Bertino JR, Levitt M, McCullough JL, Chabner B. Bertino JR, et al. Ann N Y Acad Sci. 1971 Nov 30;186:486-95. Ann N Y Acad Sci. 1971. PMID: 4943812 Review. No abstract available.
Sequential use of methotrexate, folinic acid, and cytosine arabinoside in the treatment of acute leukemia.
Greenberg ML, Waxman S. Greenberg ML, et al. Eur J Cancer (1965). 1976 Aug;12(8):617-23. doi: 10.1016/0014-2964(76)90187-0. Eur J Cancer (1965). 1976. PMID: 1086210 No abstract available.
Combination chemotherapy with folate antagonists.
Goldin A. Goldin A. Ann N Y Acad Sci. 1971 Nov 30;186:423-37. doi: 10.1111/j.1749-6632.1971.tb46997.x. Ann N Y Acad Sci. 1971. PMID: 4944292 Review. No abstract available.
[High dose methotrexate with citrovorum factor rescue therapy. (2) Measurement of methotrexate and its major metabolite, 7-hydroxymethotrexate in cerebrospinal fluid by high pressure liquid chromatography].
Tanaka J, Kinpara H, Sasaki K, Fujimoto T. Tanaka J, et al. Nihon Gan Chiryo Gakkai Shi. 1983 Jun 20;18(4):889-95. Nihon Gan Chiryo Gakkai Shi. 1983. PMID: 6604768 Japanese. No abstract available.
Toxic and therapeutic effects of methotrexate-folinic acid (Leucovorin) in advanced cancer and leukemia.
Vogler WR, Jacobs J. Vogler WR, et al. Cancer. 1971 Oct;28(4):894-901. doi: 10.1002/1097-0142(1971)28:4<894::aid-cncr2820280412>3.0.co;2-i. Cancer. 1971. PMID: 5315548 No abstract available.

See all similar articles

Cited by

[High-dose methotrexate/leucovorin adjuvant chemotherapy of osteogenic sarcoma: biochemical effects in DNA-synthesis of bone marrow cells (author's transl)].
Sauer H, Wilmanns W. Sauer H, et al. Blut. 1978 Jun 20;36(6):357-61. doi: 10.1007/BF01000594. Blut. 1978. PMID: 306851 German.
[Bone cement containing cytostatic drugs: new aspects in the treatment of malignant bone tumors. I. Experimental studies].
Langendorff HU, Jungbluth KH, Dingeldein E, Wahlig H, Delling G, Senokowitsch R. Langendorff HU, et al. Langenbecks Arch Chir. 1987;371(2):123-36. doi: 10.1007/BF01251904. Langenbecks Arch Chir. 1987. PMID: 3478546 German.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science